Financials
- Market Capitalization 336.24 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.47
ratio cours/chiffre d'affaires
11.12 K
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3263 | GALT Galectin Therapeutics Inc. - Common Stock | 4.88 USD | -8.61% | +8.69% | +86.26% | +74.29% | 321.38 M USD | ||
| 3267 | CTNM Contineum Therapeutics, Inc. - Common stock | 14.06 USD | -3.50% | -6.39% | +10.97% | -7.92% | 324.77 M USD | ||
| 3316 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.98 USD | -1.73% | +2.05% | +15.03% | +3.11% | 307.21 M USD | ||
| 3318 | FHTX Foghorn Therapeutics Inc. - Common Stock | 5.18 USD | -3.72% | -19.81% | +25.73% | +26.96% | 304.14 M USD |